Search results
BioInvent International AB: Interim Report January-March 2024
Digital Journal· 6 hours ago...and Calquence® (acalabrutinib) BioInvent regained the rights to immuno-oncology targets from Exelixis EVENTS AFTER THE END OF THE PERIOD New clinical trial collaboration and supply agreement signed with MSD to evaluate BI-1910, the company's second anti-TNFR2 antibody in combination with...
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment...
Morningstar· 2 days agoLexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company, today announced an in-license agreement with Cornell University to expedite ...
New Haven-based Arvinas signs licensing deal with Novartis worth up to $1B
Hartford Business Journal· 2 weeks agoArvinas, a clinical-stage company, is working on treatments for prostate and breast cancer. Under...
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the...
NBC 17 Raleigh· 1 week ago(Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced dosing of the first patient in the single ascending dose (SAD) Part 1 ...
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel...
Morningstar· 1 day agoDaré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it will receive a payment of $1 million as the latest installment under a grant agreement ...
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting...
NewMediaWire via Yahoo Finance· 2 weeks agoFREMONT, CA - (NewMediaWire) - April 10, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a...
ABVC Biopharma stock climbs on deal for its oncology/hematology products (NASDAQ:ABVC)
Seeking Alpha· 2 weeks agoABVC BioPharma shares surge 14% as it enters into a licensing agreement with OncoX BioPharma for its Oncology/Hematology pipeline.
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company’s In-licensing Growth...
The Kansas City Star· 6 days agoCatherine Miller Collis was instrumental in bringing about Jaguar’s recent in-license agreement for FDA-approved Gelclair®
Considerations When Conducting Decentralized Clinical Trials
The National Law Review· 1 week agoAlthough use of telehealth in clinical trials is not new, the modality was not popularized until social distancing efforts brought about by COVID-19 forced the issue. Companies interested in ...
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75%...
Investing.com· 2 weeks agoOcuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on...
